https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Immunol. Invest. 2005;34(3):245-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Immunol. Invest. 2005;34(3):245-582005-01-01 00:00:002005-01-01 00:00:00Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / J. Virol. 2005 Jan;79(1):581-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / J. Virol. 2005 Jan;79(1):581-912005-01-01 00:00:002005-01-01 00:00:00Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-59
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-592004-09-01 00:00:002004-09-01 00:00:00A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-23 / BMC Cancer 2004 Aug;4:53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-23 / BMC Cancer 2004 Aug;4:532004-08-23 00:00:002004-08-23 00:00:00The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-62004-08-05 00:00:002019-02-15 08:48:24Therapeutic cancer vaccines: using unique antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-06-01 / Int J Hyperthermia 2004 Jun;20(4):405-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-06-01 / Int J Hyperthermia 2004 Jun;20(4):405-192004-06-01 00:00:002019-02-15 09:17:50Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-912004-04-01 00:00:002004-04-01 00:00:00Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-01 / Pneumologie 2004 Apr;58(4):210-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-01 / Pneumologie 2004 Apr;58(4):210-62004-04-01 00:00:002004-04-01 00:00:00[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-532004-03-01 00:00:002019-02-15 08:48:24Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Eksp. Onkol. 2004 Mar;26(1):67-702004-03-01 00:00:002004-03-01 00:00:00Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2
